Hercules Capital: Under-Performing Portfolio Company Sold
Hercules Capital has extracted itself from a difficult credit situation with the sale of a troubled gene therapy portfolio company.
You might also like...
Aug
28
Great Elm Capital Raises $15.0 Million of Equity
3 min read
Aug
26
BRIEF: Prospect Capital's Net Asset Value Per Share Sharply Down
1 min read
Aug
26
OFS Capital: What's Happening To The BNP-Led Revolver?
4 min read
Aug
26
MSC Income Fund: New 52 Week Low. Implications For The BDC and Its External Manager - Main Street Capital.
4 min read
Aug
23
BDC Common Stocks Market Recap: Week Ended August 22, 2025
8 min read